1 of 4
/A%20rack%20of%20Sandisk%20storage%20products%20by%20ColleenMichaels%20via%20Adobe%20Stock.jpeg)
/Vertex%20Pharmaceuticals%20logo%20By%20Midea.jpeg)
Vertex Pharmaceuticals has raced ahead of the market, while analysts continue to give the stock a decidedly optimistic outlook.
/Textron%20Systems%20headquarters%20By%20JHVEPhoto.jpeg)
Textron stock has underperformed the broader market over the past year, while analysts remain moderately bullish about its prospects.
/The%20front%20of%20a%20Rocket%20Lab%20corporate%20office%20by%20Emagnetic%20via%20Shutterstock.jpg)
Rocket Lab wants to build, launch, operate, and eventually provide services through satellites, not just sell rockets.
Nebius shares tumble on plans of a $4.5 billion convertible senior notes offering. Here’s why NBIS stock is worth buying on the dip today.
Inside the Treasury Department announcement that temporarily calmed the longer end of the yield curve.
/The%20sign%20for%20Marvell%20Technology%20out%20front%20of%20a%20corporate%20office%20by%20Valeriya%20Zankovych%20via%20Shutterstock.jpg)
Marvell Technology prepares for its Q2 results with analysts expecting huge upside.
HIVE Digital Technologies is building a stronger AI-driven growth narrative, with expanding contracts adding visibility to its future revenue.
/A%20close-up%20of%20a%20SpaceX%20sign%20by%20Sundry%20Photography%20via%20Adobe%20Stock.jpeg)
What does Google's $94 billion stake in SpaceX really mean?
/Space/Cargo%20spacecraft%20in%20low-Earth%20orbit%20by%20Paopano%20via%20Shutterstock.jpg)
Rocket Lab's $12 million Space Force contract could be worth far more if Photon proves its optical communications technology, opening the door to larger defense-space opportunities.
Zoom stock rallies on a bullish Bank of America research note. Here’s why BofA recommends buying ZM shares at current levels.
